References
- Delanghe S, Delanghe JR, Speeckaert R, et al. Mechanisms and consequences of carbamoylation. Nat Rev Nephrol. 2017;13(9):580–593.
- Gillery P, Jaisson S. Post-translational modification derived products (PTMDPs): toxins in chronic diseases? Clin Chem Lab Med. 2014;52(1):33–38.
- Wang Z, Nicholls SJ, Rodriguez ER, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med. 2007;13(10):1176–1184.
- Pattison DI, Davies MJ, Hawkins CL. Reactions and reactivity of myeloperoxidase-derived oxidants: differential biological effects of hypochlorous and hypothiocyanous acids. Free Radic Res. 2012;46(8):975–995.
- Rapa SF, Di Iorio BR, Campiglia P, et al. Inflammation and oxidative stress in chronic kidney disease—potential therapeutic role of minerals, vitamins and plant-derived metabolites. IJMS. 2019;21(1):263.
- Shi J, van Veelen PA, Mahler M, et al. Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev. 2014;13(3):225–230.
- Binder V, Bergum B, Jaisson S, et al. Impact of fibrinogen carbamylation on fibrin clot formation and stability. Thromb Haemost. 2017;117(5):899–910.
- Holzer M, Gauster M, Pfeifer T, et al. Protein carbamylation renders high-density lipoprotein dysfunctional. Antioxid Redox Signal. 2011;14(12):2337–2346.
- Doué M, Okwieka A, Berquand A, et al. Carbamylation of elastic fibers is a molecular substratum of aortic stiffness. Sci Rep. 2021;11(1):17827.
- Du Clos TW. Function of C-reactive protein. Ann Med. 2000;32(4):274–278.
- Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
- Ortega O, Rodriguez I, Gallar P, et al. Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant. 2002;17(6):1105–1109.
- Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56(1):131–142.
- Cassol JPE, Scolari R, Moresco RN. Impact of albumin carbamylation on immunoturbidimetric measurement of urinary albumin. Anal Biochem. 2021;614:114047.
- Kok MB, Tegelaers FPW, van Dam B, et al. Carbamylation of albumin is a cause for discrepancies between albumin assays. Clin Chim Acta. 2014;434:6–10.
- Potempa LA, Maldonado BA, Laurent P, et al. Antigenic, electrophoretic and binding alterations of human C-reactive protein modified selectively in the absence of calcium. Mol Immunol. 1983;20(11):1165–1175.
- Seki M, Nakayama M, Sakoh T, et al. Blood urea nitrogen is independently associated with renal outcomes in japanese patients with stage 3–5 chronic kidney disease: a prospective observational study. BMC Nephrol. 2019;20(1):115.
- Koshiishi I, Imanari T. State analysis of endogenous cyanate ion in human plasma. J Pharmacobiodyn. 1990;13(4):254–258.
- Fu EL, Franko MA, Obergfell A, et al. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post–myocardial infarction patients. Am Heart J. 2019;216:20–29.
- Bazeley J, Bieber B, Li Y, et al. C-Reactive protein and prediction of 1-Year mortality in prevalent hemodialysis patients. CJASN. 2011;6(10):2452–2461.
- Cassol JPE, Moresco RN. Impact of albumin carbamylation on colorimetric measurement of albumin. Clin Lab. 2022;68(6):1302–1304.